| Name: | Citalopram EP Impurity G |
| Catalogue No. | VL920004 |
| CAS No. | 1329745-98-3 |
| Molecular Formula | C₂₅H₃₅Cl₂FN₂O₂ |
| Molecular Weight | 485.46 |
| Status | In-stock |
| IUPAC Name | 4-(Dimethylamino)-1-[1-[3-(dimethylamino)propyl]-1-(4-fluorophenyl)-1,3-dihydro-5-isobenzofuranyl]-1-butanone Dihydrochloride Salt; |
| Synonyms | EsCitalopram EP Impurity G |
| Description | Citalopram EP Impurity G (CAS No: 1329745-98-3) or EsCitalopram EP Impurity G is an impurity of Citalopram and is also used as an antidepressant drug. Citalopram is an anti-depressant that increases 5-HT transmission by blocking 5-HT uptake. Citalopram is the most beneficial 5-HT inhibitor. Citalopram also shows anti-nociceptive activity and protection against ischemia-induced neuronal death in gerbils. |
| References | Tadić, Svetlana, et al. “Development and Optimization of an HPLC Analysis of Citalopram and Its Four Nonchiral Impurities Using Experimental Design Methodology.” Journal of AOAC INTERNATIONAL, vol. 95, no. 3, May 2012, pp. 733–43, https://doi.org/10.5740/jaoacint.sge_tadic. Badulla, Wafa F. S., et al. “Capillary Electrophoresis Method for Determination of Escitalopram Oxalate in Urine Samples and Different Dosage Forms.” Journal of Chromatographic Science, vol. 58, no. 8, July 2020, pp. 759–69, |
